PATENT CLAIM ANALYSIS

Application Number: 16000338
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "233800"]

Abstract:
The present invention provides a novel chromone oxime derivative of formula (I), which is a modulator of nervous system receptors sensitive to glutamate and, furthermore, presents an advantageously high brain penetration upon oral administration. The invention also relates to a pharmaceutical composition containing this compound, and to its use for the treatment or prevention of conditions associated with altered glutamatergic signalling and/or functions, or conditions which can be affected by alteration of glutamate level or signalling, particularly acute and chronic neurological and/or psychiatric disorders.

Claim (Index 30):
A method of treating Parkinson's disease, the method comprising the administration of the compound of  claim 1  to a subject in need thereof.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 94.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15506941', '15755435', '13505235', '14403070', '14765615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7240573055292079
- 35 USC 102 Novelty (BERT): 0.6890213339101292
- Combined Prediction Score: 0.7205537083673
- Mean Citation Score: 408.775064
- Max Citation Score: 730.43243
- Similarity Product: 669.9965749028299

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test